Elevation Oncology logo

Elevation Oncology share price today

(ELEV)

Elevation Oncology share price is $0.58 & ₹49.29 as on 21 Dec 2024, 2.30 'hrs' IST

$0.58

-0.05

(-7.3%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Elevation Oncology share price in Dollar and Rupees. Guide to invest in Elevation Oncology from India. Also see the sentimental analysis on Indian investors investing in Elevation Oncology. Get details on the Indian mutual funds that are investing in Elevation Oncology. Get Analyst recommendations and forecasts along with all the Elevation Oncology's financials.

Elevation Oncology share price movements

  • Today's Low: $0.56
    Today's High: $0.66

    Day's Volatility :15.02%

  • 52 Weeks Low: $0.44
    52 Weeks High: $5.83

    52 Weeks Volatility :92.45%

Elevation Oncology Returns

PeriodElevation Oncology IncIndex (Russel 2000)
3 Months
0.83%
0.0%
6 Months
-76.33%
0.0%
1 Year
23.4%
0.0%
3 Years
-88.16%
-19.7%

Elevation Oncology Key Statistics

in dollars & INR

Previous Close
$0.6257
Open
$0.62
Today's High
$0.66
Today's Low
$0.5609
Market Capitalization
$37.0M
Today's Volume
$2.4M
52 Week High
$5.8299
52 Week Low
$0.4401
Revenue TTM
$0.0
EBITDA
$-42.0M
Earnings Per Share (EPS)
$-0.8
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-63.67%

How to invest in Elevation Oncology from India?

It is very easy for Indian residents to invest directly in Elevation Oncology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Elevation Oncology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Elevation Oncology or ELEV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Elevation Oncology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Elevation Oncology shares which would translate to 1.465 fractional shares of Elevation Oncology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Elevation Oncology, in just a few clicks!

Returns in Elevation Oncology for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Elevation Oncology investment value today

Current value as on today

₹1,25,600

Returns

₹25,600

(+25.6%)

Returns from Elevation Oncology Stock

₹23,404 (+23.4%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Elevation Oncology

-28%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Elevation Oncology on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -28% less investors are searching Elevation Oncology in the last 30 days versus the previous period.

Global Institutional Holdings in Elevation Oncology

  • TANG CAPITAL MANAGEMENT LLC

    8.05%

  • Goldman Sachs Group Inc

    6.75%

  • Farallon Capital Management, L.L.C.

    5.97%

  • Vanguard Group Inc

    5.20%

  • Bvf Inc

    5.02%

  • Aisling Capital Management LP

    4.80%

Analyst Recommendation on Elevation Oncology

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Elevation Oncology(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Elevation Oncology

What analysts predicted

Upside of 1106.9%

Current:

$0.58

Target:

$7.00

Insights on Elevation Oncology

  • Price Movement

    In the last 6 months, ELEV stock has moved down by -77.3%
  • ELEV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 5.5%
  • ELEV vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 110.1%

Elevation Oncology Technicals Summary

Sell

Neutral

Buy

Elevation Oncology is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Elevation Oncology Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Elevation Oncology Inc
-4.16%
-76.33%
23.4%
-88.16%
-94.93%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Elevation Oncology Inc
NA
NA
NA
-0.79
-0.64
-0.25
NA
1.17
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Elevation Oncology Inc
Buy
$37.0M
-94.93%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Elevation Oncology

elevation oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. we make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease. together with our peers we work towards a future in which each unique genomic testing result can be matched with a purpose-built precision medicine to bring clarity to every cancer treatment journey. our lead candidate, seribantumab, inhibits tumor growth driven by nrg1 fusions and is currently being clinically tested in the phase 2 crestone study for patients with tumors of any origin that have an nrg1 fusion. learn more about crestone at www.nrg1fusion.com. elevation oncology is backed by aisling capital, vertex ventures hc, qiming venture partners usa, driehaus capital management, and bvf partners.
Organization
Elevation Oncology
Employees
29
CEO
Mr. Joseph J. Ferra Jr.
Industry
Miscellaneous

Management People of Elevation Oncology

NameTitle
Mr. Joseph J. Ferra Jr.
CEO, President & Director
Dr. David Dornan Ph.D.
Chief Scientific Officer
Ms. Valerie Malyvanh Jansen M.D., Ph.D.
Chief Medical Officer
Ms. Tammy Furlong CPA, P.M.P.
CFO & Secretary
Mr. Ryan Bloomer
Head of Tech Ops
Candice Masse
Senior Director of Corporate Communications & Investor Relations
Mr. Robert C. Yang
Senior VP & General Counsel
Mr. Biren Shah
Senior Vice President of Business & Corporate Development

Important FAQs about investing in Elevation Oncology from India :

What is Elevation Oncology share price today?

Elevation Oncology share price today stands at $0.58, Open: $0.62 ; Previous Close: $0.63 ; High: $0.66 ; Low: $0.56 ; 52 Week High: $5.83 ; 52 Week Low: $0.44. The stock opens at $0.62, after a previous close of $0.63. The stock reached a daily high of $0.66 and a low of $0.56, with a 52-week high of $5.83 and a 52-week low of $0.44.

Can Indians buy Elevation Oncology shares?

Yes, Indians can invest in the Elevation Oncology (ELEV) from India.

With INDmoney, you can buy Elevation Oncology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Elevation Oncology at zero transaction cost.

How can I buy Elevation Oncology shares from India?

It is very easy to buy Elevation Oncology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Elevation Oncology be purchased?

Yes, you can buy fractional shares of Elevation Oncology with INDmoney app.

What are the documents required to start investing in Elevation Oncology stocks?

To start investing in Elevation Oncology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Elevation Oncology

Today’s highest price of Elevation Oncology (ELEV) is $0.66.

Today’s lowest price of Elevation Oncology (ELEV) is $0.56.

What is today's market capitalisation of Elevation Oncology

Today's market capitalisation of Elevation Oncology ELEV is 37.0M

What is the 52 Week High and Low Range of Elevation Oncology

  • 52 Week High

    $5.83

  • 52 Week Low

    $0.44

What are the historical returns of Elevation Oncology?

  • 1 Month Returns

    -4.16%

  • 3 Months Returns

    -76.33%

  • 1 Year Returns

    23.4%

  • 5 Years Returns

    -94.93%

Who is the Chief Executive Officer (CEO) of Elevation Oncology

Mr. Joseph J. Ferra Jr. is the current Chief Executive Officer (CEO) of Elevation Oncology.